section 1 - World Intellectual Property Organization
section 1 - World Intellectual Property Organization
section 1 - World Intellectual Property Organization
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
37/2000<br />
14 Sep/sep 2000 PCT Gazette - Section I - Gazette du PCT 13167<br />
(71) HANGZHOU ZHONGMEIHUADONG<br />
PHARMACEUTICAL CO. LTD.<br />
[CN/CN]; 866 Moganshan Road, Hangzhou,<br />
Zhejiang 310011 (CN).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) ZHANG, Yonghua [CN/CN];<br />
Hangzhou Zhongmeihuadong Pharmaceutical<br />
Co., Ltd., 866 Moganshan Road,<br />
Hangzhou, Zhejiang 310011 (CN).<br />
(74) CCPIT PATENT AND TRADEMARK<br />
LAW OFFICE; 8th floor, 2 Fuchengmenwai<br />
Street, Beijing 100037 (CN).<br />
(81) AE AL AM AT AU AZ BA BB BG BR BY<br />
CA CH CR CU CZ DE DK DM EE ES FI<br />
GB GD GE GH GM HR HU ID IL IN IS JP<br />
KE KG KP KR KZ LC LK LR LS LT LU<br />
LV MA MD MG MK MN MW MX NO NZ<br />
PL PT RO RU SD SE SG SI SK SL TJ TM<br />
TR TT TZ UA UG US UZ VN YU ZA ZW;<br />
AP (GH GM KE LS MW SD SL SZ TZ UG<br />
ZW); EA (AM AZ BY KG KZ MD RU TJ<br />
TM); EP (AT BE CH CY DE DK ES FI FR<br />
GB GR IE IT LU MC NL PT SE); OA (BF<br />
BJ CF CG CI CM GA GN GW ML MR NE<br />
SN TD TG).<br />
(51) 7 A61K 38/16, A61L 2/00, A61F 6/00,<br />
A61M 31/00, A61K 47/48, A61P 31/18<br />
(11) WO 00/53213 (13) A2<br />
(21) PCT/US00/06247<br />
(22) 10 Mar/mar 2000 (10.03.2000)<br />
(25) en (26) en<br />
(30) 09/267,447 12 Mar/mar 1999<br />
(12.03.1999)<br />
(30) 09/416,434 12 Oct/oct 1999<br />
(12.10.1999)<br />
(43) 14 Sep/sep 2000 (14.09.2000)<br />
US<br />
US<br />
(54) CYANOVIRIN CONJUGATES,<br />
MATRIX–ANCHORED CYANOVIRIN<br />
AND ANTI–CYANOVIRIN ANTIBODY,<br />
AND RELATED COMPOSITIONS AND<br />
METHODS OF USE<br />
CONJUGUES DE CYANOVIRINE,<br />
CYANOVIRINE FIXEE SUR MATRICE,<br />
ANTICORPS ANTI–CYANOVIRINE,<br />
ET COMPOSITIONS ET PROCEDES<br />
D’UTILISATION ASSOCIES<br />
(71) THE UNITED STATES OF AMERICA,<br />
represented by THE SECRETARY, DE-<br />
PARTMENT OF HEALTH & HUMAN<br />
SERVICES [US/US]; National Institutes of<br />
Health, Office of Technology Transfer, Suite<br />
325, 6011 Executive Boulevard, Rockville,<br />
MD 20852 (US).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) BOYD, Michael, R. [US/US]; 5217<br />
Fairgreene Way, Ijamsville, MD 21754 (US).<br />
(74) LARCHER, Carol et al. / etc.; Leydig,<br />
Voit & Mayer, Ltd., Suite 4900, Two Prudential<br />
Plaza, 180 North Stetson, Chicago,<br />
IL 60601–6780 (US).<br />
(81) AE AL AM AT AU AZ BA BB BG BR BY<br />
CA CH CN CR CU CZ DE DK DM DZ EE<br />
ES FI GB GD GE GH GM HR HU ID IL IN<br />
IS JP KE KG KP KR KZ LC LK LR LS LT<br />
LU LV MA MD MG MK MN MW MX NO<br />
NZ PL PT RO RU SD SE SG SI SK SL TJ<br />
TM TR TT TZ UA UG US UZ VN YU ZA<br />
ZW; AP (GH GM KE LS MW SD SL SZ<br />
TZ UG ZW); EA (AM AZ BY KG KZ MD<br />
RU TJ TM); EP (AT BE CH CY DE DK ES<br />
FI FR GB GR IE IT LU MC NL PT SE);<br />
OA (BF BJ CF CG CI CM GA GN GW ML<br />
MR NE SN TD TG).<br />
(51) 7 A61K 38/16, 38/19, 38/20<br />
(11) WO 00/53214 (13) A1<br />
(21) PCT/US00/06369<br />
(22) 10 Mar/mar 2000 (10.03.2000)<br />
(25) en (26) en<br />
(30) 60/124,024 11 Mar/mar 1999<br />
(11.03.1999)<br />
(43) 14 Sep/sep 2000 (14.09.2000)<br />
US<br />
(54) USE OF INTERLEUKIN–11 TO<br />
PREVENT IMMUNE–MEDIATED<br />
CYTOTOXICITY<br />
UTILISATION DE L’INTERLEUKINE<br />
11 POUR PREVENIR UNE CYTOTOXI-<br />
CITE D’ORIGINE IMMUNOLOGIQUE<br />
(71) GENETICS INSTITUTE, INC. [US/US];<br />
87 CambridgePark Drive, Cambridge, MA<br />
02140 (US).<br />
(72) KEITH, James; 28 Vine Street, Andover,<br />
MA 01810 (US). CARROLL, Joseph, M.;<br />
47 School Street, Manchester, MA 01944<br />
(US). POBER, Jordan, S.; 51 Greenbrier<br />
Drive, Guilford, CT 06437 (US).<br />
(74) CSERR, Luann; Luann Cserr Attorney at<br />
Law, 166 Wheeler Avenue, Cranston, RI<br />
02905 (US).<br />
(81) AE AL AM AT AU AZ BA BB BG BR BY<br />
CA CH CN CR CU CZ DE DK DM EE ES<br />
FI GB GD GE HR HU ID IL IN IS JP KE<br />
KG KP KR KZ LC LK LR LS LT LU LV<br />
MA MD MG MK MN MW MX NO NZ PL<br />
PT RO RU SD SE SG SI SK TJ TM TR TT<br />
UA UG UZ VN YU ZA; AP (GH GM KE<br />
LS MW SD SL SZ TZ UG ZW); EA (AM<br />
AZ BY KG KZ MD RU TJ TM); EP (AT<br />
BE CH CY DE DK ES FI FR GB GR IE IT<br />
LU MC NL PT SE); OA (BF BJ CF CG CI<br />
CM GA GN GW ML MR NE SN TD TG).<br />
Published / Publiée :(c)<br />
(51) 7 A61K 38/16, 39/00, 39/395, A61P 39/02<br />
(11) WO 00/53215 (13) A2<br />
(21) PCT/US00/06531<br />
(22) 10 Mar/mar 2000 (10.03.2000)<br />
(25) en (26) en<br />
(30) 60/124,283 12 Mar/mar 1999<br />
(12.03.1999)<br />
(43) 14 Sep/sep 2000 (14.09.2000)<br />
US<br />
(54) DEGLYCOSYLATED RICIN TOXIN A–<br />
CHAIN VACCINE<br />
VACCIN A CHAINE–A DE TOXINE DE<br />
RICIN DEGLYCOSYLEE<br />
(71) U.S. ARMY MEDICAL RESEARCH<br />
INSTITUTE OF INFECTIOUS DI-<br />
SEASES DEPARTMENT OF THE<br />
ARMY [US/US]; 504 Scott Street, Frederick,<br />
MD 21702 (US).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) WANNEMACHER, Robert, W.<br />
[US/US]; 5607 Calvert Drive, Frederick,<br />
MD 21703 (US). HEWETSON, John, F.<br />
[US/US]; 126 Kline Boulevard, Frederick,<br />
MD 21701 (US).<br />
(74) PRATT, Sana, A.; Pratt & Associates, Inc.,<br />
10821 Hillbrooke Lane, Potomac, MD 20854<br />
(US) et al. / etc.<br />
(81) AL AM AT AU AZ BA BB BG BR BY CA<br />
CH CN CU CZ DE DK EE ES FI GB GE<br />
GH GM HU ID IL IS JP KE KG KP KR KZ<br />
LC LK LR LS LT LU LV MD MG MK MN<br />
MW MX NO NZ PL PT RO RU SD SE SG<br />
SI SK SL TJ TM TR TT UA UG US UZ<br />
VN YU ZW; AP (GH GM KE LS MW SD<br />
SL SZ TZ UG ZW); EA (AM AZ BY KG<br />
KZ MD RU TJ TM); EP (AT BE CH CY<br />
DE DK ES FI FR GB GR IE IT LU MC NL<br />
PT SE); OA (BF BJ CF CG CI CM GA GN<br />
GW ML MR NE SN TD TG).<br />
(51) 7 A61K 38/17, 39/395, C07K 14/705, A61P<br />
35/00<br />
(11) WO 00/53216 (13) A2<br />
(21) PCT/EP00/01587<br />
(22) 28 Feb/fév 2000 (28.02.2000)<br />
(25) en (26) en<br />
(30) 9905124.5 5 Mar/mar 1999 GB<br />
(05.03.1999)<br />
(43) 14 Sep/sep 2000 (14.09.2000)<br />
(54) NOVEL USES<br />
NOUVELLES UTILISATIONS<br />
(71) SMITHKLINE BEECHAM BIOLOGI-<br />
CALS S.A. [BE/BE]; Rue de l’Institut 89,<br />
B–1330 Rixensart (BE).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) VINALS y de BASSOLS, Carlota<br />
[BE/BE]; SmithKline Beecham Biologicals<br />
S.A., Rue de l’Institut 89, B–1330 Rixensart<br />
(BE).<br />
(74) PRIVETT, Kathryn, Louise; SmithKline<br />
Beecham, Corporate <strong>Intellectual</strong> <strong>Property</strong>,<br />
Two New Horizons Court, Brentford, Middlesex<br />
TW8 9EP (GB).<br />
(81) AE AL AM AT AU AZ BA BB BG BR BY<br />
CA CH CN CR CU CZ DE DK DM EE ES<br />
FI GB GD GE GH GM HR HU ID IL IN<br />
IS JP KE KG KP KR KZ LC LK LR LS LT<br />
LU LV MA MD MG MK MN MW MX NO<br />
NZ PL PT RO RU SD SE SG SI SK SL TJ<br />
TM TR TT TZ UA UG US UZ VN YU ZA<br />
ZW; AP (GH GM KE LS MW SD SL SZ<br />
TZ UG ZW); EA (AM AZ BY KG KZ MD<br />
RU TJ TM); EP (AT BE CH CY DE DK ES<br />
FI FR GB GR IE IT LU MC NL PT SE);<br />
OA (BF BJ CF CG CI CM GA GN GW ML<br />
MR NE SN TD TG).